- Gene Editing
- Single Cell
Cellecta, Inc. is a leading provider of genomic products and services. Our functional genomics portfolio includes gene knockout and knockdown screening products and services, custom and genome-wide CRISPR and RNAi libraries, construct services, cell engineering services, next-generation sequencing (NGS) analysis kits and targeted RNA expression profiling products and services. We can help your discovery efforts. Learn more at www.cellecta.com
320 Logue Ave.
10 Nov 2017 Cellecta
Cellecta, Inc. and ERS Genomics announced a non-exclusive license agreement to provide Cellecta with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property for use in informing research tools and services.
CELLECTA, Inc. Launches DriverMap™ Human Genome-Wide Gene Expression Profiling Kit for 19,000 Human Genes29 Mar 2017 Cellecta
Cellecta, Inc. announced the launch of the DriverMap™ Human Genome-Wide Gene Expression Profiling kit, a targeted RNA expression profiling assay designed to easily provide a molecular snapshot of all known 19,000 human protein-coding genes from complex samples starting from as little as 10 pg of total RNA. The DriverMap assay kit includes a complete set of gene-specific and PCR-NGS primer, buffers, spike-in ERCC and positive control RNAs as well as all other reagents required to profile 24 samples and prepare them for digital expression profiling using next-generation sequencing on an Illumina platform.
CELLECTA, Inc. Introduces CRISPRa and CRISPRi Genome-Wide sgRNA Libraries and Mouse Genome-Wide CRISPR Knockout Library to Expand Functional Genomic Screening Portfolio02 Oct 2017 Cellecta
Cellecta, Inc. introduced the first commercially available CRISPRa (for activation) and CRISPRi (for inhibition) genome-wide, human and mouse pooled screening libraries to its extensive portfolio of CRISPR products and services. Cellecta also supplemented its current portfolio of CRISPR gene knockout libraries by adding a Mouse Genome-Wide CRISPR Knockout Library.